β2-adrenoceptor activation modulates skin wound healing processes to reduce scarring

Journal of Investigative Dermatology

Volumn 135, Issue 1, 2015, Pages 279-288

  Le Provost, Gabrielle S ^a   Pullar, Christine E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; ADRB2 PROTEIN, HUMAN; ADRB2 PROTEIN, ZEBRAFISH; ZEBRAFISH PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CHORIOALLANTOIS; CONTROLLED STUDY; DUROC PIG; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERPIGMENTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; SKIN INJURY; WOUND HEALING; ZEBRA FISH; ANIMAL; CELL CULTURE; CHICK EMBRYO; CYTOLOGY; DERMIS; DISEASE MODEL; FEMALE; INJURIES; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; SCAR;

ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CICATRIX; DERMIS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FOCAL ADHESIONS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, ADRENERGIC, BETA-2; SUS SCROFA; WOUND HEALING; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84925849772     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.312     Document Type: Article

References (58)

1. Ausprunk DH, Knighton DR, Folkman J (1974) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 38:237-48
2. Baker JG (2010) The selectivity of beta-adrenoceptor agonists at human beta1-, beta2-and beta3-adrenoceptors. Br J Pharmacol 160:1048-61
3. Bayat A, McGrouther DA, Ferguson MW (2003) Skin scarring. BMJ 326: 88-92
4. Beausang E, Floyd H, Dunn KW et al. (1998) A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 102:1954-61
5. Boskabady MH, Saadatinejad M (2003) Airway responsiveness to betaadrenergic agonist (salbutamol) in asthma. J Asthma 40:917-25
6. Braun LR, Lamel SA, Richmond NA et al. (2013) Topical timolol for recalcitrant wounds. JAMA Dermatol 149:1400-2
7. Chen W, Fu XB, Ge SL et al. (2006) Analysis of differentially expressed genes in fetal skin of scarless and scar-forming periods of gestational rats. Chin J Traumatol 9:94-9
8. Denda M, Fuziwara S, Inoue K (2003) Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 121:142-8
9. DiPietro LA (2013) Angiogenesis and scar formation in healing wounds. Curr Opin Rheumatol 25:87-91
10. Dostmann WR, Taylor SS, Genieser HG et al. (1990) Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem 265: 10484-91
11. Dugina V, Fontao L, Chaponnier C et al. (2001) Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci 114:3285-96
12. Fairbairn L, Kapetanovic R, Beraldi D et al. (2013) Comparative Analysis of Monocyte Subsets in the Pig. J Immunol 190:6389-96
13. Fantin A, Vieira JM, Gestri G et al. (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116:829-40
14. Gallant CL, Olson ME, Hart DA (2004) Molecular, histologic, and gross phenotype of skin wound healing in red Duroc pigs reveals an abnormal healing phenotype of hypercontracted, hyperpigmented scarring. Wound Repair Regen 12:305-19
15. Gallant-Behm CL, Hart DA (2006) Genetic analysis of skin wound healing and scarring in a porcine model. Wound Repair Regen 14: 46-54
16. Gallant-Behm CL, Hildebrand KA, Hart DA (2008) The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen 16:226-33
17. Hayward PG, Robson MC (1991) Animal models of wound contraction. Prog Clin Biol Res 365:301-12
18. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127:526-37
19. Hinz B, Celetta G, Tomasek JJ et al. (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-41
20. Insel PA, Murray F, Yokoyama U et al. (2012) Cyclic AMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol 166:447-56
21. Ishiguro S, Akasaka Y, Kiguchi H et al. (2009) Basic fibroblast growth factor induces down-regulation of alpha-smooth muscle actin and reduction of myofibroblast areas in open skin wounds. Wound Repair Regen 17:617-25
22. Kimmel CB, Ballard WW, Kimmel SR et al. (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203:253-310
23. Kratz G (1998) Modeling of wound healing processes in human skin using tissue culture. Microsc Res Tech 42:345-50
24. Lev-Tov H, Dahle S, Moss J et al. (2013) Successful treatment of a chronic venous leg ulcer using a topical beta-blocker. J Am Acad Dermatol 69:e204-5
25. Levesque M, Feng Y, Jones RA et al. (2013) Inflammation drives wound hyperpigmentation in zebrafish by recruiting pigment cells to sites of tissue damage. Dis Model Mech 6:508-15
26. Lucas T, Waisman A, Ranjan R et al. (2010) Differential roles of macrophages in diverse phases of skin repair. J Immunol 184:3964-77
27. Manahan MN, Peters P, Scuderi S et al. (2014) Topical timolol for a chronic ulcer-a case with its own control. Med J Aust 200:49-50
28. Margolis DJ, Hoffstad O, Isseroff RR (2007) Association between the use of beta-adrenergic receptor agents and the development of venous leg ulcers. Arch Dermatol 143:1275-80
29. Miyake M, Ishii M, Koyama N et al. (2010) 1-tert-butyl-3-[6-(3,5-dimethoxyphenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrest. J Pharmacol Exp Ther 332:795-802
30. Montagna W, Yun JS (1964) The skin of the domestic Pig. J Invest Dermatol 42:11-21
31. Nagatsu T, Stjarne L (1998) Catecholamine synthesis and release. Overview. Adv Pharmacol 42:1-14
32. Ogawa R, Akaishi S, Huang C et al. (2011) Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 78:68-76
33. Ono I, Akasaka Y, Kikuchi R et al. (2007) Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 15:617-23
34. Pullar CE, Isseroff RR (2005) Beta 2-adrenergic receptor activation delays dermal fibroblast-mediated contraction of collagen gels via a cAMPdependent mechanism. Wound Repair Regen 13:405-11
35. Pullar CE, Grahn JC, Liu W et al. (2006a) Beta2-adrenergic receptor activation delays wound healing. FASEB J 20:76-86
36. Pullar CE, Rizzo A, Isseroff RR (2006b) beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. J Biol Chem 281:21225-35
37. Pullar CE, Manabat-Hidalgo CG, Bolaji RS et al. (2008) beta-Adrenergic receptor modulation of wound repair. Pharmacol Res 58:158-64
38. Pullar CE, Le Provost GS, O'Leary AP et al. (2012) beta2AR Antagonists and beta2AR Gene Deletion Both Promote Skin Wound Repair Processes. J Invest Dermatol 132:2076-84
39. Redd MJ, Cooper L, Wood W et al. (2004) Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans R Soc Lond B Biol Sci 359:777-84
40. Renshaw SA, Loynes CA, Trushell DM et al. (2006) A transgenic zebrafish model of neutrophilic inflammation. Blood 108:3976-8
41. Scott MG, Swan C, Jobson TM et al. (1999) Effects of a range of beta2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells. Br J Pharmacol 128:721-9
42. Shaw TJ, Martin P (2009) Wound repair at a glance. J Cell Sci 122:3209-13
43. Sindrilaru A, Scharffetter-Kochanek K (2013) Disclosure of the culprits: macrophages-versatile regulators of wound healing. Adv Wound Care (New Rochelle) 2:357-68
44. Sivamani RK, Pullar CE, Manabat-Hidalgo CG et al. (2009) Stress-mediated increases in systemic and local epinephrine impair skin wound healing: potential new indication for beta blockers. PLoS Med 6:e12
45. Stramer BM, Mori R, Martin P (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127:1009-17
46. Sullivan T, Smith J, Kermode J et al. (1990) Rating the burn scar. J Burn Care Rehabil 11:256-60
47. Sullivan TP, Eaglstein WH, Davis SC et al. (2001) The Pig as a model for human wound healing. Wound Repair Regen 9:66-76
48. Szpaderska AM, Walsh CG, Steinberg MJ et al. (2005) Distinct patterns of angiogenesis in oral and skin wounds. J Dent Res 84:309-14
49. Takenaka H, Yasuno H, Kishimoto S (2002) Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. Arch Dermatol Res 294:331-8
50. Tang JC, Dosal J, Kirsner RS (2012) Topical timolol for a refractory wound. Dermatol Surg 38:135-8
51. Tiede S, Ernst N, Bayat A et al. (2009) Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann Anat 191:33-44
52. Tomasek JJ, Gabbiani G, Hinz B et al. (2002) Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-63
53. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24
54. Wallukat G (2002) The beta-adrenergic receptors. Herz 27:683-90
55. Wang ZP, Nishimura Y, Shimada Y et al. (2009) Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. Gene 446: 18-27
56. Weisser SB, McLarren KW, Kuroda E et al. (2013) Generation and characterization of murine alternatively activated macrophages. Methods Mol Biol 946:225-39
57. Westerfield M (1994) The Zebrafish Book: A Guide To The Laboratory Use Of The Zebrafish (Brachydanio rerio). 2.1 edn. Eugene: University of oregon Press
58. Wilgus TA, Ferreira AM, Oberyszyn TM et al. (2008) Regulation of scar formation by vascular endothelial growth factor. Lab Invest 88:579-90